Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Shares Issued (2020 - 2025)

Foghorn Therapeutics (FHTX) has 6 years of Shares Issued data on record, last reported at $483000.0 in Q4 2025.

  • For Q4 2025, Shares Issued rose 11975.0% year-over-year to $483000.0; the TTM value through Dec 2025 reached $483000.0, down 81.51%, while the annual FY2025 figure was $483000.0, 81.51% down from the prior year.
  • Shares Issued reached $483000.0 in Q4 2025 per FHTX's latest filing, up from -$393000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $102.2 million in Q2 2024 and bottomed at -$100.8 million in Q3 2024.
  • Average Shares Issued over 5 years is $2.4 million, with a median of $196500.0 recorded in 2025.
  • The widest YoY moves for Shares Issued: up 99156.31% in 2024, down 49067.32% in 2024.
  • A 5-year view of Shares Issued shows it stood at $41.5 million in 2021, then plummeted by 99.96% to $16000.0 in 2022, then skyrocketed by 11012.5% to $1.8 million in 2023, then crashed by 99.78% to $4000.0 in 2024, then soared by 11975.0% to $483000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $483000.0 in Q4 2025, -$393000.0 in Q3 2025, and $254000.0 in Q2 2025.